Delphi consensus on oral anticoagulation management in special clinical situations in the cardiology setting.
| Autor: | Gómez Doblas JJ; Hospital Virgen de la Victoria, Campus de Teatinos, S/N, Puerto de la Torre, 29010, Málaga., García-Moll X; Hospital de la Santa Creu i Sant Pau, C/de Sant Quintí, 89, Horta-Guinardó, 08025, Barcelona., Bover Freire R; Hospital Clínico San Carlos, Calle del Prof Martín Lagos, S/N, Moncloa - Aravaca, 28040, Madrid, CIBERCV., Juanatey CG; Hospital Lucus Augusti, Rúa Dr. Ulises Romero, 1, 27003, Lugo., Morillas M; Hospital de Galdakao, Labeaga Auzoa, 48960, Galdakao, Bizkaia., Muñoz AV; Hospital Marina Salud, Av. Marina Alta, s/n, 03700, Denia, Alicante., Escobar C; Hospital Universitario La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Future cardiology [Future Cardiol] 2024; Vol. 20 (13), pp. 695-708. Date of Electronic Publication: 2024 Oct 22. |
| DOI: | 10.1080/14796678.2024.2343550 |
| Abstrakt: | Background: Management of oral anticoagulation (OAC) can be challenging, such as in complex cases of nonvalvular atrial fibrillation (NVAF). Materials & methods: A Delphi study comprising two rounds was used for gathering expert opinion through an online questionnaire (83 items grouped in 8 dimensions) on OAC management in specific clinical settings. Results: Consensus was reached for 79 items (95%) in round 1. Experts recommended direct-acting oral anticoagulants (DOACs) for pericardioversion, uninterrupted OAC for catheter ablation, and dual therapy with a DOAC and clopidogrel after percutaneous coronary intervention. They also recommended restarting OAC with a DOAC after an intracranial haemorrhage. Conclusion: The expert-based recommendations obtained may contribute to standardizing and guiding the management of OAC in complex clinical situations in cardiology. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|